Stay updated on Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page revision label was updated from v3.5.4 to v3.5.5, indicating a minor metadata update. No study data or visible content appears to be affected.
    Difference
    0.1%
    Check dated 2026-06-05T11:59:33.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The related topics header and its entries (Lung cancer and MedlinePlus Genetics) were removed, reducing quick links to disease-related resources on the page.
    Difference
    0.2%
    Check dated 2026-05-29T08:40:11.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.5.3 to v3.5.4, signaling a deployment/build update. No study content or parameters appear to be modified.
    Difference
    0.1%
    Check dated 2026-05-15T02:17:18.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Revision: v3.5.3 has replaced Revision: v3.5.2 as the page version label, indicating a new site release; no study information or visible content appears to be affected.
    Difference
    0.1%
    Check dated 2026-04-30T17:22:13.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Site revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T11:56:40.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0. Removed Lung cancer, related topics: MedlinePlus Genetics, and Revision: v3.4.3 from the related topics.
    Difference
    0.2%
    Check dated 2026-03-18T22:51:46.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial page.